LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/NJ Ortho Surgeon Admits to Performing Unnecessary Surgeries
Legal & Regulatory and Reimbursement

NJ Ortho Surgeon Admits to Performing Unnecessary Surgeries

June 30, 2021 2 min read Premium comments

Advertisement

Secondary#cliftonorthopedicassociates#evangelosmegariotis

The New Jersey Office of the Attorney General and orthopedic surgeon Evangelos Megariotis, M.D. have entered into an agreement settling professional misconduct and gross negligence allegations.

The settlement resolves allegations contained in a 2018 complaint that Attorney General Gurbir S. Grewal filed with the New Jersey State Board of Medical Examiners. The complaint alleged that Dr. Megariotis’ treatment of nine patients between 2012 and 2017 included such allegations of professional misconduct and gross negligence as: “keeping patients on pain pills for years without cause; failing to diagnose and/or treat patients’ underlying conditions; improperly treating conditions outside his [Dr. Megariotis] area of expertise without referring patients to specialists; and performing surgeries without first establishing a legitimate medical need.”

The complaint included specific examples of Dr. Megariotis’ alleged improper behavior. Examples of the alleged behavior include purportedly “[f]ailing to conduct any routine urine or blood testing, and/or to conduct regular lookups on the NJ [New Jersey] Prescription Monitoring Program to ensure patients’ proper use of CDS [Controlled Dangerous Substances], as required.” Other examples of the alleged behavior include when Dr. Megariotis supposedly performed “surgery on one patient’s knee, and another patient’s shoulder, despite a lack of diagnostic findings to support the medical necessity for the procedures.”

Dr. Megariotis owned and operated Clifton, New Jersey-based Clifton Orthopedic Associates, P.A. He closed his practice on December 31, 2018.

In 2019, an administrative hearing occurred during which Dr. Megariotis denied all of the allegations. Prior to the judge making his decision, Dr. Megariotis voluntarily agreed to resolve the matter. The parties then entered into an agreement and a final consent order was entered earlier this month (June 2021).

In the consent order, Dr. Megariotis agreed to retire his license to practice medicine and surgery in New Jersey. This retirement is to be deemed a “permanent revocation.” He also agreed to return his medical license and Controlled Dangerous Substances registration to the New Jersey State Board of Medical Examiners. Dr. Megariotis agreed to refrain from engaging in activities considered to be the practice of medicine. He also agreed to pay $48,000 in costs.

In the press release, Grewal commented, “Doctors who demonstrate a lack of professional judgement and utter disregard for patient safety by indiscriminately prescribing addictive pain medicine pose a grave danger to their patients and the public at large.”

Grewal continued, “We will not tolerate this behavior from our licensed professionals.”

The press release also noted that Dr. Megariotis is currently “facing federal criminal charges in connection with his prescribing of CDS [Controlled Dangerous Substances].”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy